COMMUNIQUÉS West-GlobeNewswire

CORRECTING AND REPLACING – Dr. Anosh Ahmed Announces Major Expansion of COVID Testing Contracts Across U.S. and International Markets
07/07/2025
Dr. Anosh Ahmed expands U.S. and international COVID testing contracts with focus on compliance, fraud prevention, and trusted public health services CHICAGO, July 07, 2025 (GLOBE NEWSWIRE) -- In a release issued under [...]
Press release: SEQUANA MEDICAL ANNOUNCES NEW SHARE CAPITAL AMOUNT AND NEW NUMBER OF SHARES
07/07/2025
SEQUANA MEDICAL ANNOUNCES NEW SHARE CAPITAL AMOUNT AND NEW NUMBER OF SHARES Ghent, Belgium, 7 July 2025 – Sequana Medical NV (Euronext Brussels: SEQUA) (the " Company " or " Sequana Medical "), a pioneer in the [...]
Ipsen - Half year statement - 2025 06 30
07/07/2025
Half-year statement of IPSEN liquidity agreement with NATIXIS ODDO BHF PARIS, 07 JULY 2025 - Ipsen (Euronext: IPN; ADR: IPSEY) announced today that under the liquidity agreement entrusted by IPSEN S.A. to NATIXIS ODDO [...]
Ipsen - Bilan semestriel - 30 juin 2025
07/07/2025
Bilan semestriel du contrat de liquidité entre IPSEN et NATIXIS ODDO BHF PARIS, FRANCE, 07 JUILLET 2025 - Ipsen (Euronext : IPN ; ADR: IPSEY) annonce aujourd'hui qu’au titre du contrat de liquidité confié par IPSEN S.A [...]
CORRECTION – Dr. Anosh Ahmed Supports Trump’s Statement on Chicago, Citing Ongoing Public Safety and Policy Challenges
07/07/2025
Physician and Republican leader voices concern over rising crime and strained social infrastructure in the city Image by Dr. Anosh Ahmed CHICAGO, July 07, 2025 (GLOBE NEWSWIRE) -- In a release issued under the same [...]
The National Lung Health Alliance Warns that Politicizing Immunization Risks Lives – Especially for Canadians with Lung Conditions
07/07/2025
The NLHA says wasted vaccines are a failure of health promotion, not coverage TORONTO, July 07, 2025 (GLOBE NEWSWIRE) -- The National Lung Health Alliance (NLHA), representing Canada’s leading lung health organizations [...]
Smith+Nephew expands market-leading fixation strength of Q-FIX™ All-Suture Anchor portfolio with new knotless option
07/07/2025
Smith+Nephew (LSE:SN, NYSE:SNN), the global medical technology company, announces the release of its Q-FIX KNOTLESS All-Suture Anchor for soft tissue-to-bone fixation indications across multiple joint spaces including [...]
Joybird’s Treehouse to Host Free Webinar on Academic Success for Underserved Students
07/07/2025
Joybird’s Treehouse Announces Free Webinar to Improve Academic Outcomes for Underserved Students Dallas, TX , July 07, 2025 (GLOBE NEWSWIRE) -- Joybird’s Treehouse , a culturally responsive education platform founded by [...]
The American Society of Pain and Neuroscience (ASPN) Publishes Consensus Guidelines for the Use of 60-Day Peripheral Nerve Stimulation (PNS) Therapy, Highlighting Strong Clinical Applications for SPR® SPRINT® PNS
07/07/2025
CLEVELAND, July 07, 2025 (GLOBE NEWSWIRE) -- Recently, ASPN published the first clinical guidelines focused specifically on the use of 60-day PNS (SPRINT PNS), offering evidence-based best practice recommendations. It [...]
Corza Medical Announces the Launch of the Expanded Onatec Ophthalmic Suture Portfolio
07/07/2025
PARSIPPANY, New Jersey, July 07, 2025 (GLOBE NEWSWIRE) -- Corza Medical, a leading global medical technology company, today announced the launch of its expanded Onatec Ophthalmic Suture Portfolio. This marks a [...]
Skin Care and Laser Physicians of Beverly Hills Welcomes Double Board-Certified Dermatologist
07/07/2025
Dr. Cory Kosche Brings His Expertise to the Los Angeles-Based Skin Care Team LOS ANGELES, July 07, 2025 (GLOBE NEWSWIRE) -- Skin Care and Laser Physicians of Beverly Hills are proud to introduce the newest addition to [...]
Immix Biopharma Announces Accelerated NEXICART-2 Clinical Trial Progress in relapsed/refractory AL Amyloidosis
07/07/2025
– National Footprint of NEXICART-2 Trial Sites Expanded – – On track for first Biologics License Application (BLA) approved cell therapy in unaddressed orphan indication – – NEXICART-2 interim results were presented at [...]
Nudj Health Appoints Dr. Padmaja Patel as Chief Medical Officer to Advance Lifestyle Medicine Services
07/07/2025
PASADENA, Calif., July 07, 2025 (GLOBE NEWSWIRE) -- Nudj Health, the leading AI-powered lifestyle medicine services company, is proud to announce the appointment of Dr. Padmaja Patel as Chief Medical Officer of [...]
Synfini Adds $8.9 Million Discovery Funding to Speed Small Molecule Drug Development
07/07/2025
Innovative System Combines Physical and Virtual Chemistry with Discovery-Focused AI and Robotic Automation to Find Better Molecules Faster and Less Expensively MENLO PARK, Calif., July 07, 2025 (GLOBE NEWSWIRE) -- [...]
SELLAS Life Sciences Appoints Linghua Wang, MD, PhD, to Scientific Advisory Board
07/07/2025
NEW YORK, July 07, 2025 (GLOBE NEWSWIRE) -- SELLAS Life Sciences Group, Inc. (NASDAQ: SLS) (“SELLAS’’ or the “Company”), a late-stage clinical biopharmaceutical company focused on the development of novel therapies for [...]
Mustang Bio Granted Orphan Drug Designation by U.S. FDA for MB-101 (IL13Ra2-targeted CAR T-cells) to Treat Astrocytomas and Glioblastoma
07/07/2025
In an ongoing Phase 1 trial published in Nature Medicine, MB-101 was well-tolerated and 50% of patients achieved stable disease or better with two partial responses and two complete responses lasting 7.5 and 66+ months [...]
Autonomix Medical, Inc. Announces Release of the Next CEO Corner Segment
07/07/2025
THE WOODLANDS, TX, July 07, 2025 (GLOBE NEWSWIRE) -- Autonomix Medical, Inc. (NASDAQ: AMIX) (“Autonomix” or the “Company”), a medical device company dedicated to advancing precision nerve-targeted treatments, today [...]
Conduit Pharmaceuticals Files New Patents Following AI-Driven Combination Discoveries
07/07/2025
Includes Conduit’s first composition of matter patent filing for AZD5658 and multiple new combination filings for AZD1656 and AZD5658 Patents derived from AI-led analysis conducted in partnership with Sarborg Limited [...]
Silo Pharma Advances PTSD Drug SPC-15 Toward Planned 2025 IND Submission with Pre-Clinical Study Data Expected in Q3 2025
07/07/2025
Planned submission of IND application in 2025; Phase 1 clinical trial to follow if IND application approved No new PTSD drug approvals in the U.S. in nearly 25 years; large potential addressable market for SPC-15 [...]

Pages